Medicover will continue to work according to its long-term strategic agenda which includes retaining and growing the customer base, expanding service offering, and pursuing operational excellence. Furthermore, the company is continuously driving digital differentiation and remains selective around M&A.

"Over the last three years, we have managed to organically grow revenue with 14.6 percent per year, well ahead of our financial target, and with an adjusted EBITDA margin of 15.5percent, truly demonstrating our ability to generate superior growth. Furthermore, we have reached significant operational milestones including expansion to new geographies and segments as well as making significant investments in digitalisation across divisions. Together with our clear strategic roadmap, makes us well-placed for continued profitable organic growth where we intend to exceed EUR 2.2 billion in organic revenue and EUR 350 million in organic adjusted EBITDA in 2025", says Fredrik Rågmark, CEO of Medicover.

Speakers at the Capital Markets Day include Fredrik Rågmark, CEO, Staffan Ternström, COO Diagnostic Services, John Stubbington, COO Healthcare Services, and Joe Ryan, CFO.

The webcast can be watched here (https://edge.media-server.com/mmc/p/4zbyquc8).

Information on the Capital Markets Day and live stream could be found on the website (https://www.medicover.com/capital-markets-day).

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2022, Medicover had revenue of €1,510 million and more than 44,000 employees. For more information, go to www.medicover.com